Global Neurodegenerative Diseases Therapeutics Supply, Demand and Key Producers, 2023-2029

Page: 110

Published Date: 05 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Neurodegenerative Diseases Therapeutics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Neurodegenerative Diseases Therapeutics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Neurodegenerative Diseases Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurodegenerative Diseases Therapeutics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Neurodegenerative Diseases Therapeutics total market, 2018-2029, (USD Million)
Global Neurodegenerative Diseases Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Neurodegenerative Diseases Therapeutics total market, key domestic companies and share, (USD Million)
Global Neurodegenerative Diseases Therapeutics revenue by player and market share 2018-2023, (USD Million)
Global Neurodegenerative Diseases Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)
Global Neurodegenerative Diseases Therapeutics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Neurodegenerative Diseases Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AB Science SA, AbbVie Inc., Acadia Pharmaceuticals Inc., Biogen Inc., F. Hoffmann La Roche Ltd., H Lundbeck AS, Mitsubishi Chemical Holdings Corp., Novartis AG and Sanofi, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neurodegenerative Diseases Therapeutics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Neurodegenerative Diseases Therapeutics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Neurodegenerative Diseases Therapeutics Market, Segmentation by Type
Multiple Sclerosis Therapeutics
Alzheimer's Disease Therapeutics
Parkinson's Disease Therapeutics
Parkinson's Disease Therapeutics
Others

Global Neurodegenerative Diseases Therapeutics Market, Segmentation by Application
Child
Aldult

Companies Profiled:
AB Science SA
AbbVie Inc.
Acadia Pharmaceuticals Inc.
Biogen Inc.
F. Hoffmann La Roche Ltd.
H Lundbeck AS
Mitsubishi Chemical Holdings Corp.
Novartis AG
Sanofi
Teva Pharmaceutical Industries Ltd

Key Questions Answered
1. How big is the global Neurodegenerative Diseases Therapeutics market?
2. What is the demand of the global Neurodegenerative Diseases Therapeutics market?
3. What is the year over year growth of the global Neurodegenerative Diseases Therapeutics market?
4. What is the total value of the global Neurodegenerative Diseases Therapeutics market?
5. Who are the major players in the global Neurodegenerative Diseases Therapeutics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Neurodegenerative Diseases Therapeutics Introduction
    1.2 World Neurodegenerative Diseases Therapeutics Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Neurodegenerative Diseases Therapeutics Total Market by Region (by Headquarter Location)
        1.3.1 World Neurodegenerative Diseases Therapeutics Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Neurodegenerative Diseases Therapeutics Market Size (2018-2029)
        1.3.3 China Neurodegenerative Diseases Therapeutics Market Size (2018-2029)
        1.3.4 Europe Neurodegenerative Diseases Therapeutics Market Size (2018-2029)
        1.3.5 Japan Neurodegenerative Diseases Therapeutics Market Size (2018-2029)
        1.3.6 South Korea Neurodegenerative Diseases Therapeutics Market Size (2018-2029)
        1.3.7 ASEAN Neurodegenerative Diseases Therapeutics Market Size (2018-2029)
        1.3.8 India Neurodegenerative Diseases Therapeutics Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Neurodegenerative Diseases Therapeutics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Neurodegenerative Diseases Therapeutics Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029)
    2.2 World Neurodegenerative Diseases Therapeutics Consumption Value by Region
        2.2.1 World Neurodegenerative Diseases Therapeutics Consumption Value by Region (2018-2023)
        2.2.2 World Neurodegenerative Diseases Therapeutics Consumption Value Forecast by Region (2024-2029)
    2.3 United States Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029)
    2.4 China Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029)
    2.5 Europe Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029)
    2.6 Japan Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029)
    2.7 South Korea Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029)
    2.8 ASEAN Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029)
    2.9 India Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029)

3 World Neurodegenerative Diseases Therapeutics Companies Competitive Analysis
    3.1 World Neurodegenerative Diseases Therapeutics Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Neurodegenerative Diseases Therapeutics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Neurodegenerative Diseases Therapeutics in 2022
        3.2.3 Global Concentration Ratios (CR8) for Neurodegenerative Diseases Therapeutics in 2022
    3.3 Neurodegenerative Diseases Therapeutics Company Evaluation Quadrant
    3.4 Neurodegenerative Diseases Therapeutics Market: Overall Company Footprint Analysis
        3.4.1 Neurodegenerative Diseases Therapeutics Market: Region Footprint
        3.4.2 Neurodegenerative Diseases Therapeutics Market: Company Product Type Footprint
        3.4.3 Neurodegenerative Diseases Therapeutics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Neurodegenerative Diseases Therapeutics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Neurodegenerative Diseases Therapeutics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Neurodegenerative Diseases Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Neurodegenerative Diseases Therapeutics Consumption Value Comparison
        4.2.1 United States VS China: Neurodegenerative Diseases Therapeutics Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Neurodegenerative Diseases Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Neurodegenerative Diseases Therapeutics Companies and Market Share, 2018-2023
        4.3.1 United States Based Neurodegenerative Diseases Therapeutics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Neurodegenerative Diseases Therapeutics Revenue, (2018-2023)
    4.4 China Based Companies Neurodegenerative Diseases Therapeutics Revenue and Market Share, 2018-2023
        4.4.1 China Based Neurodegenerative Diseases Therapeutics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Neurodegenerative Diseases Therapeutics Revenue, (2018-2023)
    4.5 Rest of World Based Neurodegenerative Diseases Therapeutics Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Neurodegenerative Diseases Therapeutics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Neurodegenerative Diseases Therapeutics Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Neurodegenerative Diseases Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Multiple Sclerosis Therapeutics
        5.2.2 Alzheimer's Disease Therapeutics
        5.2.3 Parkinson's Disease Therapeutics
        5.2.4 Parkinson's Disease Therapeutics
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Neurodegenerative Diseases Therapeutics Market Size by Type (2018-2023)
        5.3.2 World Neurodegenerative Diseases Therapeutics Market Size by Type (2024-2029)
        5.3.3 World Neurodegenerative Diseases Therapeutics Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Neurodegenerative Diseases Therapeutics Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Child
        6.2.2 Aldult
    6.3 Market Segment by Application
        6.3.1 World Neurodegenerative Diseases Therapeutics Market Size by Application (2018-2023)
        6.3.2 World Neurodegenerative Diseases Therapeutics Market Size by Application (2024-2029)
        6.3.3 World Neurodegenerative Diseases Therapeutics Market Size by Application (2018-2029)

7 Company Profiles
    7.1 AB Science SA
        7.1.1 AB Science SA Details
        7.1.2 AB Science SA Major Business
        7.1.3 AB Science SA Neurodegenerative Diseases Therapeutics Product and Services
        7.1.4 AB Science SA Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 AB Science SA Recent Developments/Updates
        7.1.6 AB Science SA Competitive Strengths & Weaknesses
    7.2 AbbVie Inc.
        7.2.1 AbbVie Inc. Details
        7.2.2 AbbVie Inc. Major Business
        7.2.3 AbbVie Inc. Neurodegenerative Diseases Therapeutics Product and Services
        7.2.4 AbbVie Inc. Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 AbbVie Inc. Recent Developments/Updates
        7.2.6 AbbVie Inc. Competitive Strengths & Weaknesses
    7.3 Acadia Pharmaceuticals Inc.
        7.3.1 Acadia Pharmaceuticals Inc. Details
        7.3.2 Acadia Pharmaceuticals Inc. Major Business
        7.3.3 Acadia Pharmaceuticals Inc. Neurodegenerative Diseases Therapeutics Product and Services
        7.3.4 Acadia Pharmaceuticals Inc. Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Acadia Pharmaceuticals Inc. Recent Developments/Updates
        7.3.6 Acadia Pharmaceuticals Inc. Competitive Strengths & Weaknesses
    7.4 Biogen Inc.
        7.4.1 Biogen Inc. Details
        7.4.2 Biogen Inc. Major Business
        7.4.3 Biogen Inc. Neurodegenerative Diseases Therapeutics Product and Services
        7.4.4 Biogen Inc. Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Biogen Inc. Recent Developments/Updates
        7.4.6 Biogen Inc. Competitive Strengths & Weaknesses
    7.5 F. Hoffmann La Roche Ltd.
        7.5.1 F. Hoffmann La Roche Ltd. Details
        7.5.2 F. Hoffmann La Roche Ltd. Major Business
        7.5.3 F. Hoffmann La Roche Ltd. Neurodegenerative Diseases Therapeutics Product and Services
        7.5.4 F. Hoffmann La Roche Ltd. Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 F. Hoffmann La Roche Ltd. Recent Developments/Updates
        7.5.6 F. Hoffmann La Roche Ltd. Competitive Strengths & Weaknesses
    7.6 H Lundbeck AS
        7.6.1 H Lundbeck AS Details
        7.6.2 H Lundbeck AS Major Business
        7.6.3 H Lundbeck AS Neurodegenerative Diseases Therapeutics Product and Services
        7.6.4 H Lundbeck AS Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 H Lundbeck AS Recent Developments/Updates
        7.6.6 H Lundbeck AS Competitive Strengths & Weaknesses
    7.7 Mitsubishi Chemical Holdings Corp.
        7.7.1 Mitsubishi Chemical Holdings Corp. Details
        7.7.2 Mitsubishi Chemical Holdings Corp. Major Business
        7.7.3 Mitsubishi Chemical Holdings Corp. Neurodegenerative Diseases Therapeutics Product and Services
        7.7.4 Mitsubishi Chemical Holdings Corp. Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Mitsubishi Chemical Holdings Corp. Recent Developments/Updates
        7.7.6 Mitsubishi Chemical Holdings Corp. Competitive Strengths & Weaknesses
    7.8 Novartis AG
        7.8.1 Novartis AG Details
        7.8.2 Novartis AG Major Business
        7.8.3 Novartis AG Neurodegenerative Diseases Therapeutics Product and Services
        7.8.4 Novartis AG Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Novartis AG Recent Developments/Updates
        7.8.6 Novartis AG Competitive Strengths & Weaknesses
    7.9 Sanofi
        7.9.1 Sanofi Details
        7.9.2 Sanofi Major Business
        7.9.3 Sanofi Neurodegenerative Diseases Therapeutics Product and Services
        7.9.4 Sanofi Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Sanofi Recent Developments/Updates
        7.9.6 Sanofi Competitive Strengths & Weaknesses
    7.10 Teva Pharmaceutical Industries Ltd
        7.10.1 Teva Pharmaceutical Industries Ltd Details
        7.10.2 Teva Pharmaceutical Industries Ltd Major Business
        7.10.3 Teva Pharmaceutical Industries Ltd Neurodegenerative Diseases Therapeutics Product and Services
        7.10.4 Teva Pharmaceutical Industries Ltd Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
        7.10.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Neurodegenerative Diseases Therapeutics Industry Chain
    8.2 Neurodegenerative Diseases Therapeutics Upstream Analysis
    8.3 Neurodegenerative Diseases Therapeutics Midstream Analysis
    8.4 Neurodegenerative Diseases Therapeutics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Neurodegenerative Diseases Therapeutics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Neurodegenerative Diseases Therapeutics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Neurodegenerative Diseases Therapeutics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Neurodegenerative Diseases Therapeutics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Neurodegenerative Diseases Therapeutics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Neurodegenerative Diseases Therapeutics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Neurodegenerative Diseases Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Neurodegenerative Diseases Therapeutics Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Neurodegenerative Diseases Therapeutics Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Neurodegenerative Diseases Therapeutics Players in 2022
    Table 12. World Neurodegenerative Diseases Therapeutics Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Neurodegenerative Diseases Therapeutics Company Evaluation Quadrant
    Table 14. Head Office of Key Neurodegenerative Diseases Therapeutics Player
    Table 15. Neurodegenerative Diseases Therapeutics Market: Company Product Type Footprint
    Table 16. Neurodegenerative Diseases Therapeutics Market: Company Product Application Footprint
    Table 17. Neurodegenerative Diseases Therapeutics Mergers & Acquisitions Activity
    Table 18. United States VS China Neurodegenerative Diseases Therapeutics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Neurodegenerative Diseases Therapeutics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Neurodegenerative Diseases Therapeutics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Neurodegenerative Diseases Therapeutics Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Neurodegenerative Diseases Therapeutics Revenue Market Share (2018-2023)
    Table 23. China Based Neurodegenerative Diseases Therapeutics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Neurodegenerative Diseases Therapeutics Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Neurodegenerative Diseases Therapeutics Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Neurodegenerative Diseases Therapeutics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Neurodegenerative Diseases Therapeutics Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Neurodegenerative Diseases Therapeutics Revenue Market Share (2018-2023)
    Table 29. World Neurodegenerative Diseases Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Neurodegenerative Diseases Therapeutics Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Neurodegenerative Diseases Therapeutics Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Neurodegenerative Diseases Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Neurodegenerative Diseases Therapeutics Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Neurodegenerative Diseases Therapeutics Market Size by Application (2024-2029) & (USD Million)
    Table 35. AB Science SA Basic Information, Area Served and Competitors
    Table 36. AB Science SA Major Business
    Table 37. AB Science SA Neurodegenerative Diseases Therapeutics Product and Services
    Table 38. AB Science SA Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. AB Science SA Recent Developments/Updates
    Table 40. AB Science SA Competitive Strengths & Weaknesses
    Table 41. AbbVie Inc. Basic Information, Area Served and Competitors
    Table 42. AbbVie Inc. Major Business
    Table 43. AbbVie Inc. Neurodegenerative Diseases Therapeutics Product and Services
    Table 44. AbbVie Inc. Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. AbbVie Inc. Recent Developments/Updates
    Table 46. AbbVie Inc. Competitive Strengths & Weaknesses
    Table 47. Acadia Pharmaceuticals Inc. Basic Information, Area Served and Competitors
    Table 48. Acadia Pharmaceuticals Inc. Major Business
    Table 49. Acadia Pharmaceuticals Inc. Neurodegenerative Diseases Therapeutics Product and Services
    Table 50. Acadia Pharmaceuticals Inc. Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Acadia Pharmaceuticals Inc. Recent Developments/Updates
    Table 52. Acadia Pharmaceuticals Inc. Competitive Strengths & Weaknesses
    Table 53. Biogen Inc. Basic Information, Area Served and Competitors
    Table 54. Biogen Inc. Major Business
    Table 55. Biogen Inc. Neurodegenerative Diseases Therapeutics Product and Services
    Table 56. Biogen Inc. Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Biogen Inc. Recent Developments/Updates
    Table 58. Biogen Inc. Competitive Strengths & Weaknesses
    Table 59. F. Hoffmann La Roche Ltd. Basic Information, Area Served and Competitors
    Table 60. F. Hoffmann La Roche Ltd. Major Business
    Table 61. F. Hoffmann La Roche Ltd. Neurodegenerative Diseases Therapeutics Product and Services
    Table 62. F. Hoffmann La Roche Ltd. Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. F. Hoffmann La Roche Ltd. Recent Developments/Updates
    Table 64. F. Hoffmann La Roche Ltd. Competitive Strengths & Weaknesses
    Table 65. H Lundbeck AS Basic Information, Area Served and Competitors
    Table 66. H Lundbeck AS Major Business
    Table 67. H Lundbeck AS Neurodegenerative Diseases Therapeutics Product and Services
    Table 68. H Lundbeck AS Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. H Lundbeck AS Recent Developments/Updates
    Table 70. H Lundbeck AS Competitive Strengths & Weaknesses
    Table 71. Mitsubishi Chemical Holdings Corp. Basic Information, Area Served and Competitors
    Table 72. Mitsubishi Chemical Holdings Corp. Major Business
    Table 73. Mitsubishi Chemical Holdings Corp. Neurodegenerative Diseases Therapeutics Product and Services
    Table 74. Mitsubishi Chemical Holdings Corp. Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Mitsubishi Chemical Holdings Corp. Recent Developments/Updates
    Table 76. Mitsubishi Chemical Holdings Corp. Competitive Strengths & Weaknesses
    Table 77. Novartis AG Basic Information, Area Served and Competitors
    Table 78. Novartis AG Major Business
    Table 79. Novartis AG Neurodegenerative Diseases Therapeutics Product and Services
    Table 80. Novartis AG Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Novartis AG Recent Developments/Updates
    Table 82. Novartis AG Competitive Strengths & Weaknesses
    Table 83. Sanofi Basic Information, Area Served and Competitors
    Table 84. Sanofi Major Business
    Table 85. Sanofi Neurodegenerative Diseases Therapeutics Product and Services
    Table 86. Sanofi Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Sanofi Recent Developments/Updates
    Table 88. Teva Pharmaceutical Industries Ltd Basic Information, Area Served and Competitors
    Table 89. Teva Pharmaceutical Industries Ltd Major Business
    Table 90. Teva Pharmaceutical Industries Ltd Neurodegenerative Diseases Therapeutics Product and Services
    Table 91. Teva Pharmaceutical Industries Ltd Neurodegenerative Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 92. Global Key Players of Neurodegenerative Diseases Therapeutics Upstream (Raw Materials)
    Table 93. Neurodegenerative Diseases Therapeutics Typical Customers
List of Figure
    Figure 1. Neurodegenerative Diseases Therapeutics Picture
    Figure 2. World Neurodegenerative Diseases Therapeutics Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Neurodegenerative Diseases Therapeutics Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Neurodegenerative Diseases Therapeutics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Neurodegenerative Diseases Therapeutics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Neurodegenerative Diseases Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Neurodegenerative Diseases Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Neurodegenerative Diseases Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Neurodegenerative Diseases Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Neurodegenerative Diseases Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Neurodegenerative Diseases Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Neurodegenerative Diseases Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 13. Neurodegenerative Diseases Therapeutics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Neurodegenerative Diseases Therapeutics Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Neurodegenerative Diseases Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Neurodegenerative Diseases Therapeutics by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Neurodegenerative Diseases Therapeutics Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Neurodegenerative Diseases Therapeutics Markets in 2022
    Figure 27. United States VS China: Neurodegenerative Diseases Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Neurodegenerative Diseases Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Neurodegenerative Diseases Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Neurodegenerative Diseases Therapeutics Market Size Market Share by Type in 2022
    Figure 31. Multiple Sclerosis Therapeutics
    Figure 32. Alzheimer's Disease Therapeutics
    Figure 33. Parkinson's Disease Therapeutics
    Figure 34. Parkinson's Disease Therapeutics
    Figure 35. Others
    Figure 36. World Neurodegenerative Diseases Therapeutics Market Size Market Share by Type (2018-2029)
    Figure 37. World Neurodegenerative Diseases Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Neurodegenerative Diseases Therapeutics Market Size Market Share by Application in 2022
    Figure 39. Child
    Figure 40. Aldult
    Figure 41. Neurodegenerative Diseases Therapeutics Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Neurodegenerative Diseases Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Neurodegenerative Diseases Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 04 Jan 2023

date Medical Care

According to our (Global Info Research) latest study, the global Neurodegenerative Diseases Therapeutics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Neurodegenerative Diseases Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Neurodegenerative Diseases Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 24 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Neurodegenerative Diseases Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Neurodegenerative Diseases Therapeutics

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>